Celadon Pharmaceuticals Plc (AIM:CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 11.50
+2.28 (19.78%)
Jun 27, 2025, 4:35 PM GMT+1
Celadon Pharmaceuticals Market Cap
Celadon Pharmaceuticals has a market cap or net worth of 7.92 million as of June 27, 2025. Its market cap has decreased by -84.62% in one year.
Market Cap
7.92M
Enterprise Value
12.70M
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.50
Market Cap Chart
Since March 29, 2022, Celadon Pharmaceuticals's market cap has decreased from 89.42M to 7.92M, a decrease of -91.15%. That is a compound annual growth rate of -52.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 7.92M | -23.33% |
| Dec 31, 2024 | 10.33M | -86.01% |
| Dec 29, 2023 | 73.84M | 137.10% |
| Dec 30, 2022 | 31.14M | -65.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.54B |
| GSK plc | 56.88B |
| Haleon | 34.55B |
| Smith & Nephew | 9.34B |
| ConvaTec Group | 5.91B |
| Hikma Pharmaceuticals | 4.47B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.34B |